Workflow
盘龙药业: 半年报财务报表

Core Viewpoint - The financial report of Shaanxi Panlong Pharmaceutical Group Co., Ltd. for the first half of 2025 shows an increase in total assets and net profit compared to the same period in 2024, indicating a positive growth trend in the company's financial performance [2][5][6]. Financial Summary Assets - Total assets at the end of the first half of 2025 amounted to CNY 2,362,246,494.51, an increase from CNY 2,280,023,009.54 at the beginning of the year, reflecting a growth of approximately 3.6% [2][3]. - Current assets totaled CNY 1,855,373,268.19, up from CNY 1,771,523,291.39, marking an increase of about 4.7% [2][3]. - Non-current assets slightly decreased to CNY 506,873,226.32 from CNY 508,499,718.15, a decline of approximately 0.3% [2][3]. Liabilities - Total liabilities increased to CNY 696,000,341.43 from CNY 642,840,255.08, representing a rise of about 8.2% [3][4]. - Current liabilities rose to CNY 485,824,666.12, compared to CNY 446,110,297.49, an increase of approximately 8.9% [3][4]. - Non-current liabilities also increased to CNY 210,175,675.31 from CNY 196,729,957.59, reflecting a growth of about 6.8% [3][4]. Equity - Total equity reached CNY 1,666,246,153.08, up from CNY 1,637,182,754.46, indicating an increase of approximately 1.8% [3][4]. - Retained earnings increased to CNY 688,550,110.23 from CNY 659,732,692.20, a growth of about 4.4% [3][4]. Revenue and Profit - Operating revenue for the first half of 2025 was CNY 574,023,000.14, compared to CNY 455,356,633.75 in the same period of 2024, marking an increase of approximately 26% [5][6]. - Net profit for the first half of 2025 was CNY 59,979,473.51, slightly up from CNY 59,435,447.41 in 2024, indicating a marginal growth of about 0.9% [5][6]. - Basic and diluted earnings per share remained stable at CNY 0.57 [5][6]. Cash Flow - Net cash flow from operating activities was CNY 62,620,899.02, down from CNY 111,157,587.41 in the previous year, indicating a decrease of approximately 43.7% [7]. - Cash and cash equivalents at the end of the period were CNY 1,166,765,970.54, slightly down from CNY 1,164,710,997.88 [7].